A Phase II Trial of Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancers of Follicular Origin, Who Are Thyroglobulin Positive/RAI [Radioiodine] Unresponsive.

Trial Profile

A Phase II Trial of Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancers of Follicular Origin, Who Are Thyroglobulin Positive/RAI [Radioiodine] Unresponsive.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2011

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Thyroid cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Aug 2011 Planned end date changed from 1 Aug 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 02 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top